gusperimus has been researched along with Disease Exacerbation in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kobayashi, E; Murakami, T; Ohsawa, I; Uemoto, S | 1 |
| Ebisui, C; Fukunishi, T; Hanafusa, T; Ichikawa, Y; Kyo, M; Nagano, S; Nojima, M; Tsubakihara, Y; Yazawa, K | 1 |
2 other study(ies) available for gusperimus and Disease Exacerbation
| Article | Year |
|---|---|
Control of cyclosporine A-induced tumor progression using 15-deoxyspergualin for rat cardiac transplantation.
Topics: Animals; Caspase 3; Caspase 7; Cell Proliferation; Colonic Neoplasms; Cyclosporine; Disease Progression; Graft Survival; Guanidines; Heart; Heart Transplantation; Immunosuppressive Agents; Liver; Liver Neoplasms; Luciferases; NF-kappa B; Rats; Rats, Inbred F344; Rats, Inbred Lew | 2007 |
Acute rejection and the therapeutic choice of drug.
Topics: Acute Disease; Adult; Cyclosporine; Disease Progression; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Guanidines; Histocompatibility Testing; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Muromonab-CD3; Retrospective Studies; Tacrolimus; Time Factors; Treatment Outcome | 2000 |